Bonne본느

Bonne's TTM revenue fell sharply and losses deepened through H1 2026, while the share price has risen strongly over three months.

Bonne is a Korean cosmetics company doing ODM work for brand customers and running its own brands. Trailing twelve-month revenue is about ₩38.4B, with an operating loss of about ₩8.6B and a net loss of about ₩21.9B, and borrowings of about ₩7.4B exceed cash of about ₩4.2B. The share price closed at ₩5,200 on 19 October 2026, up about 234% over three months but down from a 52-week high of ₩9,680.

What stands out

• Revenue fell 33% in 2025 to ₩46.0B after a 5.8% decline in 2024, and the trailing figures show further weakness into 2026.
• The company reported losses in 2025 and H1 2026 with negative operating and net margins, and ROE of -60.8% on a trailing basis.
• Liabilities are about 99% of equity and free cash flow is negative at about -₩7.2B on a trailing basis.
• Recent filings include a rights offering (paid-in capital increase) decision amended in September, a change of largest shareholder on 12 October, and a lawsuit filed or ruled on 16 October.
• Foreign ownership fell from 0.6% to 0.3% over 60 days, while retail investors were net sellers of about ₩821M over the last 20 days. No news headlines were provided in the data.

What to watch

• Details and timing of the rights offering and its effect on share count and funding, which the data does not specify.
• Outcome of the lawsuit reported on 16 October and the trust agreement termination for own share acquisition, as the filings give no detail on impact.
• Whether revenue and losses stabilise in the next results, since the data has no forecasts or analyst estimates.